Dr. Ruth O'Hara
Ruth O'Hara, Ph.D. is the Senior Associate Dean for Research (SADR) at the Stanford University School of Medicine, a position she has held since 2019, and the Lowell W. and Josephine Q. Berry Endowed Professor in the Department of Psychiatry and Behavioral Sciences. In her role as SADR, she provides institutional leadership for a biomedical research enterprise comprising more than 2000 faculty and representing the highest NIH funding per researcher in the United States, with more than $573 million in NIH funding in 2025 alone. Dr. O'Hara has simultaneously served as Principal Investigator of the NIH/NCATS-funded Stanford Clinical and Translational Science Award (CTSA), the flagship NIH mechanism for accelerating translational research since 2019. In recognition of her national leadership in this domain, Dr. O'Hara has served on and co-chaired the NIH/NCATS CTSA Program Steering Committee providing strategic leadership for accelerating translational research locally, regionally, and nationally, as part of a collaborative network of more than 60 leading medical institutions across the country. Dr. O'Hara is a highly productive and continuously NIH-funded clinical and translational scientist in her own right, with a research program spanning neuroimaging, sleep biology, cognitive phenotyping, and psychiatric disorders across the lifespan. Her publication record includes work in Science Translational Medicine, JAMA Neurology, the American Journal of Psychiatry, and numerous other leading journals, with over two decades of competitive extramural funding from NIMH, NIA, NICHD, NIDCR, and NCATS. Dr. O’Hara has also served as the Director of the Sierra-Pacific MIRECC Translational Research Core and as the national Director of the 28-site, VA Advanced Fellowship Program in Mental Health Research and Treatment which has graduated over 500 MD and PhD Fellows into independent academic clinical research career positions. Dr. O’Hara’s leadership roles at Stanford University and the Palo Alto VA, in the CTSA consortium, and in multiple national translational science forums gives her an exceptionally rare, system-level understanding of the structural, regulatory, and human dimensions of moving biomedical discovery and technological advances from bench to bedside in order to improve outcomes for patients, families and communities.
